Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | PDE2A | O00408 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1970199 | 0.76 | PDE2A (0.52) | PDE2AAKR1C3AKR1C2PTGS1KDM1A | |
| SCHEMBL218054 | 0.76 | TDP1 (0.67) | LMNACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL18542736 | 0.74 | TSHR (0.43) | CYP3A4PDE2ACA12CA1CA2 | |
| SCHEMBL19667860 | 0.74 | IDO1 (0.43) | IDO1PDE2AAKR1C3AKR1C2PTGS1 | |
| SCHEMBL19680105 | 0.72 | AKR1C3 (0.50) | LMNACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19667876 | 0.70 | PRSS1 (0.38) | PDE2AAKR1C3AKR1C2PTGS1KDM1A | |
| SCHEMBL17517024 | 0.70 | ALDH1A1 (0.62) | LMNACYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL8250 | 0.69 | — | — | |
| SCHEMBL240645 | 0.69 | MEN1 (0.50) | CYP3A4TDP1PDE2ACA6CA14 | |
| SCHEMBL18856615 | 0.69 | AKR1C3 (0.36) | PDE2AAKR1C3AKR1C2PTGS1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107108490-B | Method for producing nitrogen-containing pentafluorosulfanylbenzene compound | 宇部兴产株式会社 | 2019-12-31 | — | — | CN | disclosed |
| US-9868701-B2 | Method for producing nitrogen-containing pentafluorosulfanylbenzene compound | UBE INDUSTRIES, LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-20170349545-A1 | METHOD FOR PRODUCING NITROGEN-CONTAINING PENTAFLUOROSULFANYLBENZENE COMPOUND | UBE CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
| US-20160296499-A1 | Spiroindoline Antiparasitic Derivatives | ZOETIS SERVICES LLC | 2016-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349545-A1 | METHOD FOR PRODUCING NITROGEN-CONTAINING PENTAFLUOROSULFANYLBENZENE COMPOUND | NPM1, PYM1, FPR2 | LMNA 3309/4885CYP1A2 180/4885CYP3A4 253/4885 |
| US-20160296499-A1 | Spiroindoline Antiparasitic Derivatives | PKD2, PKD1, AVPR2 | LMNA 2530/4885CYP1A2 121/4885CYP3A4 141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.